Anika Therapeutics
ANIK
162 hedge funds and large institutions have $465M invested in Anika Therapeutics in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 49 reducing their positions, and 15 closing their positions.
60% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 15
37% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 49
11% more capital invested
Capital invested by funds: $418M → $465M (+$47M)
6% more funds holding
Funds holding: 153 → 162 (+9)
1% more call options, than puts
Call options by funds: $4.03M | Put options by funds: $4M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$11.7M |
| 2 |
GAM
Gotham Asset Management
New York
|
+$10.5M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$4.14M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$3.87M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$26.4M |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$7.58M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.49M |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$6.45M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$4.48M |
ANIK Hedge Fund Activity: Q2 2014 in Review
162 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q2 2014, worth a combined $465M — up 11% from $418M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ANIK positions and 15 closed out — a net gain of 9 holders — while 67 added to existing stakes and 49 trimmed.
The largest buyer was Thompson Siegel & Walmsley, adding an estimated $11.7M. The largest seller was Systematic Financial Management, cutting an estimated $26.4M.
- 162 institutional investors held Anika Therapeutics (ANIK) as of Q2 2014, up from 153 in Q1 2014.
- Funds reported $465M of Anika Therapeutics stock for Q2 2014, up 11% quarter-over-quarter.
- 24 funds opened new Anika Therapeutics positions in Q2 2014 and 15 closed out, a net change of +9 holders.
- The largest Anika Therapeutics buyer in Q2 2014 was Thompson Siegel & Walmsley, an estimated $11.7M added.
- The largest Anika Therapeutics seller in Q2 2014 was Systematic Financial Management, an estimated $26.4M sold.
Based on aggregated 13F filings for Q2 2014.